Evidence map›Paper›PMID 31915287›Full record

ArticleJournal of clinical microbiology2020

Evaluation of the ResistancePlus MG FleXible Assay for Detection of Wild-Type and 23S rRNA-Mutated Mycoplasma genitalium Strains.

Suhella Tulsiani Drud, Peter Njuguna, Samantha Ebeyan, Simon Erskine, Mette Holm, Susanne Cramer Johansson, Lit Yeen Tan, Jorgen Skov Jensen

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Treatment Approaches for RefractoryOpen forum infectious diseases · 2026
    Article
  3. Article
  4. AutomatedMicrobiology spectrum · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Point-by-Point Progress: Gonorrhea Point of Care Tests.Expert review of molecular diagnostics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Suhella Tulsiani DrudDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark stul@ssi.dk jsj@ssi.dk.
Peter NjugunaSpeeDx Pty. Ltd., National Innovation Centre, Eveleigh, NSW, Australia.
Samantha EbeyanSpeeDx Pty. Ltd., National Innovation Centre, Eveleigh, NSW, Australia.
Simon ErskineSpeeDx Pty. Ltd., National Innovation Centre, Eveleigh, NSW, Australia.
Mette HolmDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Susanne Cramer JohanssonDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Lit Yeen TanSpeeDx Pty. Ltd., National Innovation Centre, Eveleigh, NSW, Australia.
Jorgen Skov JensenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark stul@ssi.dk jsj@ssi.dk.ORCID 0000-0002-7464-7435
Data61 · AUStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance in

Indexed as

Mycoplasma genitaliumMycoplasma InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumansMacrolidesReproducibility of ResultsRNA, Ribosomal, 23SAnti-Bacterial AgentsMacrolidesRNA, Ribosomal, 23SdetectiondiagnosticsGeneXpert Dxmacrolide resistancemolecular assayMycoplasma genitaliumnear-patientResistancePlus MG FleXible

Identifiers

PMID31915287
PMCPMC7041592
OpenAlexW2999376400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.